Looking forward, the pharmaceutical source chain is poised for continued evolution and transformation driven by technological progress, regulatory developments, and transforming marketplace dynamics. Quite a few crucial developments and alternatives are likely to form the future of the pharmaceutical source chain:The affected person-centric source